Γ

SynBioBeta Speaker

Clayton Rabideau

CEO

Syntensor Incorporated

Clayton is the founder of Syntensor, a startup that develops frontier models for drug development and human genetics with a particular focus on predicting the underlying drivers of clinical trial outcomes and trait prediction from human genomes."

SynBioBeta 2025 - Session Speaker

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Previous Speakers Include

Sign Up
Sign Up